The use of the PSA test for prostate cancer has become very controversial since some studies have shown no increase in overall survival using this test.
Now some researchers have suggested, through analysis of results, a more specific screening regimen.
They found that if men at age 60 had a PSA of under 2.0, further screening would not have an affect on life spans. However if it was 2 or over, they found that annual testing was worthwhile.
To me this sounds like a good approach. Under the age of 60 Prostate cancer can be aggressive, so I will continue to test annually. However, over the age of 60 I will give my patients the option of following these recommendations.
No comments:
Post a Comment